TAVI in nonagenarians, what do we know so far?
Transcatheter aortic valve implantation (TAVI) has become a widely used therapeutic strategy to treat symptomatic severe aortic stenosis. Certain randomized clinical trials available have already described the prognostic benefit of this technique in elderly patients with high or very high surgical r...
Guardado en:
Autores principales: | Pablo Díez-Villanueva, Fernando Rivero |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
Permanyer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c6f1b4ee0ba499fb09a81b330496ece |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019) -
Spaceflight-induced neuroplasticity in humans as measured by MRI: what do we know so far?
por: Angelique Van Ombergen, et al.
Publicado: (2017) -
Heart Rate Variability and Cardiovascular Fitness: What We Know so Far
por: Souza HCD, et al.
Publicado: (2021) -
Identifying High-Risk NASH Patients: What We Know so Far
por: Schulz M, et al.
Publicado: (2020) -
Black students applying and admitted to medicine in the province of Quebec, Canada: what do we know so far?
por: Jean-Michel Leduc, et al.
Publicado: (2021)